Neowise Biotechnology
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors (NCT07266298) | Neowise Biotechnology | 2025-12-01 |
Track Neowise Biotechnology automatically
Every clearance here is in the API, with alerts when new ones post.